728 related articles for article (PubMed ID: 34977908)
1. Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.
Pahnke J; Bascuñana P; Brackhan M; Stefan K; Namasivayam V; Koldamova R; Wu J; Möhle L; Stefan SM
Free Neuropathol; 2021; 2():. PubMed ID: 34977908
[TBL] [Abstract][Full Text] [Related]
2. Physicochemistry shapes bioactivity landscape of pan-ABC transporter modulators: Anchor point for innovative Alzheimer's disease therapeutics.
Namasivayam V; Stefan K; Gorecki L; Korabecny J; Soukup O; Jansson PJ; Pahnke J; Stefan SM
Int J Biol Macromol; 2022 Sep; 217():775-791. PubMed ID: 35839956
[TBL] [Abstract][Full Text] [Related]
3. Scaffold fragmentation and substructure hopping reveal potential, robustness, and limits of computer-aided pattern analysis (C@PA).
Namasivayam V; Silbermann K; Pahnke J; Wiese M; Stefan SM
Comput Struct Biotechnol J; 2021; 19():3269-3283. PubMed ID: 34141145
[TBL] [Abstract][Full Text] [Related]
4. Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.
Namasivayam V; Stefan K; Pahnke J; Stefan SM
Comput Struct Biotechnol J; 2021; 19():6490-6504. PubMed ID: 34976306
[TBL] [Abstract][Full Text] [Related]
5. The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease.
Behl T; Kaur I; Sehgal A; Kumar A; Uddin MS; Bungau S
Mol Neurobiol; 2021 Apr; 58(4):1564-1582. PubMed ID: 33215389
[TBL] [Abstract][Full Text] [Related]
6. The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease.
Bossaerts L; Cacace R; Van Broeckhoven C
Mol Neurodegener; 2022 Apr; 17(1):31. PubMed ID: 35477481
[TBL] [Abstract][Full Text] [Related]
7. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
8. Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2.
Silbermann K; Shah CP; Sahu NU; Juvale K; Stefan SM; Kharkar PS; Wiese M
Eur J Med Chem; 2019 Feb; 164():193-213. PubMed ID: 30594677
[TBL] [Abstract][Full Text] [Related]
9. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
[TBL] [Abstract][Full Text] [Related]
10. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
Abuznait AH; Kaddoumi A
ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
[TBL] [Abstract][Full Text] [Related]
11. The A-B-C of small-molecule ABC transport protein modulators: From inhibition to activation-a case study of multidrug resistance-associated protein 1 (ABCC1).
Wiese M; Stefan SM
Med Res Rev; 2019 Nov; 39(6):2031-2081. PubMed ID: 30941807
[TBL] [Abstract][Full Text] [Related]
12. ABC Transporters and the Alzheimer's Disease Enigma.
Wolf A; Bauer B; Hartz AM
Front Psychiatry; 2012; 3():54. PubMed ID: 22675311
[TBL] [Abstract][Full Text] [Related]
13. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
14. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
15. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
16. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
17. Karanjin interferes with ABCB1, ABCC1, and ABCG2.
Michaelis M; Rothweiler F; Nerreter T; Sharifi M; Ghafourian T; Cinatl J
J Pharm Pharm Sci; 2014; 17(1):92-105. PubMed ID: 24735762
[TBL] [Abstract][Full Text] [Related]
18. ABCA5 regulates amyloid-β peptide production and is associated with Alzheimer's disease neuropathology.
Fu Y; Hsiao JH; Paxinos G; Halliday GM; Kim WS
J Alzheimers Dis; 2015; 43(3):857-69. PubMed ID: 25125465
[TBL] [Abstract][Full Text] [Related]
19. VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters.
Ji N; Yang Y; Cai CY; Lei ZN; Wang JQ; Gupta P; Teng QX; Chen ZS; Kong D; Yang DH
Front Pharmacol; 2018; 9():1236. PubMed ID: 30425643
[TBL] [Abstract][Full Text] [Related]
20. Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro.
Cihalova D; Staud F; Ceckova M
Cancer Chemother Pharmacol; 2015 Jul; 76(1):105-16. PubMed ID: 25986678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
